Martínez-García MÁ, Ojeda-Ojeda, Miriam, Rodriguez-Martin, Eulalia, Insenser, Maria, Moncayo, Samuel, Alvarez-Blasco, Francisco, Luque-Ramirez, Manuel, Escobar-Morreale, Hector F..

TLR2 and TLR4 Surface and Gene Expression in White Blood Cells after Fasting and Oral Glucose, Lipid and Protein Challenges: Influence of Obesity and Sex Hormones

Biomolecules 2020. 10(1): . Number of citations: 16

[doi:10.3390/biom10010111]

Mariscal-Rodríguez A, Villar Guimerans LM, López-Trascasa M, Hernández González M, Moga Naranjo E.

Laboratory guidelines for the diagnosis of patients with cryoglobulinaemic syndrome.

REVISTA CLINICA ESPANOLA 2019. 219(9): 505-513.

[doi:10.1016/j.rce.2018.10.006]

Muñoz-San Martín M, Reverter G, Robles-Cedeño R, Buxò M, Ortega FJ, Gómez I, Tomàs-Roig J, Celarain N, Villar LM, Perkal H, Fernández-Real JM, Quintana E, Ramió-Torrentà L.

Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions.

JOURNAL OF NEUROINFLAMMATION 2019. 16(1): 220-220. Number of citations: 28

[doi:10.1186/s12974-019-1590-5]

Alonso-Canovas A, Tembl Ferrairó JI, Martínez-Torres I, Lopez-Sendon Moreno JL, Parees-Moreno I, Monreal-Laguillo E, Pérez-Torre P, Toledano Delgado R, García Ribas G, Sastre Bataller I, Masjuan J, Martinez-Castrillo JC, Walter U.

Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.

PARKINSONISM & RELATED DISORDERS 2019. 68: 40-45. Number of citations: 9

[doi:10.1016/j.parkreldis.2019.09.032]

Moreira A, Alari-Pahissa E, Munteis E, Vera A, Zabalza A, Llop M, Villarrubia N, Costa-García M, Álvarez-Lafuente R, Villar LM, López-Botet M, Martínez-Rodríguez JE.

Adaptive Features of Natural Killer Cells in Multiple Sclerosis.

Frontiers in immunology 2019. 10: 2403-2403. Number of citations: 13

[doi:10.3389/fimmu.2019.02403]

Fissolo N, Cervera-Carles L, Villar Guimerans LM, Lleó A, Clarimón J, Drulovic J, Dujmovic I, Voortman M, Khalil M, Gil E, Navarro L, Álvarez-Cermeño JC, Montalban X, Comabella M.

Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis.

MULTIPLE SCLEROSIS JOURNAL 2019. 25(11): 1535-1538. Number of citations: 3

[doi:10.1177/1352458518786055]

Fraussen J, Marquez S, Takata K, Beckers L, Montes Diaz G, Zografou C, Van Wijmeersch B, Villar LM, O'Connor KC, Kleinstein SH, Somers V.

Phenotypic and Ig Repertoire Analyses Indicate a Common Origin of IgD - CD27 - Double Negative B Cells in Healthy Individuals and Multiple Sclerosis Patients.

JOURNAL OF IMMUNOLOGY 2019. 203(6): 1650-1664. Number of citations: 16

[doi:10.4049/jimmunol.1801236]

Cuello JP, Martínez Ginés ML, Kuhle J, García Domínguez JM, Lozano Ros A, Romero Delgado F, Higueras Y, Meldaña Rivera A, Goicochea Briceño H, García-Tizon Larroca S, de-León Ruiz J, Michalak Z, Barro C, Álvarez Lafuente R, Medina Heras S, Fernández Velasco JI, Tejeda-Velarde A, Domínguez-Mozo MI, Muriel A, de Andrés C, Villar LM.

Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study.

EUROPEAN JOURNAL OF NEUROLOGY 2019. 26(9): 1200-1204. Number of citations: 11

[doi:10.1111/ene.13965]

Mestre L, Carrillo-Salinas FJ, Mecha M, Feliú A, Espejo C, Álvarez-Cermeño JC, Villar LM, Guaza C.

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.

Frontiers in immunology 2019. 10: 1374-1374. Number of citations: 23

[doi:10.3389/fimmu.2019.01374]

Fernandez O, Tintore M, Saiz A, Calles-Hernandez MC, Comabella M, Ramio-Torrenta L, Oterino A, Izquierdo G, Tellez N, Garcia-Merino JA, Brieva L, Arnal-Garcia C, Aladro Y, Mendibe-Bilbao MM, Meca-Lallana JE, Romero-Pinel L, Martinez-Gines ML, Arroyo R, Oreja-Guevara C, Costa-Frossard L, Carrascal P, Rodriguez-Antiguedad A.

Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II).

REVISTA DE NEUROLOGIA 2019. 68(11): 468-479.

[doi:10.33588/rn.6811.2019121]

van Rossum JA, Killestein J, Villar LM, Riskind PN, Freedman MS, Teunissen C.

gMS-Classifier1 does not predict disability progression in multiple sclerosis.

MULTIPLE SCLEROSIS JOURNAL 2019. 25(7): 1010-1011.

[doi:10.1177/1352458518798048]

Pérez-Miralles F, Prefasi D, García-Merino A, Ara JR, Izquierdo G, Meca-Lallana V, Gascón F, Martínez-Ginés ML, Ramió-Torrentà L, Costa-Frossard L, Fernández Ó, Moreno-García S, Maurino J, Casanova-Estruch B.

Perception of stigma in patients with primary progressive multiple sclerosis.

MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL 2019. 5(2): . Number of citations: 5

[doi:10.1177/2055217319852717]

Sainz de la Maza S, Medina S, Villarrubia N, Costa-Frossard L, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM.

Factors associated with dimethyl fumarate-induced lymphopenia.

JOURNAL OF THE NEUROLOGICAL SCIENCES 2019. 398: 4-8. Number of citations: 19

[doi:10.1016/j.jns.2019.01.007]

Medina S, Sainz de la Maza S, Villarrubia N, Álvarez-Lafuente R, Costa-Frossard L, Arroyo R, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM.

Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients.

Annals of Clinical and Translational Neurology 2019. 6(2): 355-363. Number of citations: 10

[doi:10.1002/acn3.711]

Tejeda Velarde, Amalia, Medina Heras, Silvia, Villar Guimerans, Luisa Maria.

Biomarkers for Multiple Sclerosis

RSC Drug Discovery Series 2019. 70: 55-75.

[doi:10.1039/9781788016070]

Villarrubia N, Rodríguez-Martín E, Alari-Pahissa E, Aragón L, Castillo-Triviño T, Eixarch H, Ferrer JM, Martínez-Rodríguez JE, Massot M, Pinto-Medel MJ, Prada Á, Rodríguez-Acevedo B, Urbaneja P, Gascón-Gimenez F, Herrera G, Hernández-Clares R, Salgado MG, Oterino A, Segundo DS, Cuello JP, Gil-Herrera J, Cámara C, Gómez-Gutiérrez M, Martínez-Hernández E, Meca-Lallana V, Moga E, Muñoz-Calleja C, Querol L, Presas-Rodríguez S, Teniente-Serra A, Vlagea A, Muriel A, Roldán E, Villar LM.

Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.

CLINICA CHIMICA ACTA 2019. 488: 135-142. Number of citations: 1

[doi:10.1016/j.cca.2018.11.008]

Malhotra S, Villar LM, Costa C, Midaglia L, Cubedo M, Medina S, Fissolo N, Río J, Castilló J, Álvarez-Cermeño JC, Sánchez A, Montalban X, Comabella M.

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients.

JOURNAL OF NEUROINFLAMMATION 2018. 15(1): 296-296. Number of citations: 5

[doi:10.1186/s12974-018-1336-9]

Perez Perez, S., Dominguez Mozo, M. I., Medina, S., Villarubia, N., Alonso Gomez, A., Garcia Martinez, M. A., Costa Frossard, L., Alvarez Cermeno, J. C., Arroyo Gonzalez, R., Villar Guimerans, L. M., Alvarez Lafuente, R..

Short chain fatty acids levels in plasma of multiple sclerosis patients: a correlation with the disability of the disease and the activation of the immune system

MULTIPLE SCLEROSIS JOURNAL 2018. 24: 601-602. Number of citations: 1